Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy

Overview

Journal Cancer Discov

Specialty Oncology

Date 2024 May 14

PMID 38742767

Authors

Abrar Choudhury

Martha A Cady

Calixto-Hope G Lucas

Hinda Najem

Joanna J Phillips

Brisa Palikuqi

Naomi Zakimi

Tara Joseph

Janeth O Birrueta

William C Chen

Nancy A Oberheim Bush

Shawn L Hervey-Jumper

Ophir D Klein

Christine M Toedebusch

Craig M Horbinski

Stephen T Magill

Aparna Bhaduri

Arie Perry

Peter J Dickinson

Amy B Heimberger

Alan Ashworth

Elizabeth E Crouch

David R Raleigh

Affiliations

Soon will be listed here.

Abstract

Meningiomas are the most common primary intracranial tumors. Treatments for patients with meningiomas are limited to surgery and radiotherapy, and systemic therapies remain ineffective or experimental. Resistance to radiotherapy is common in high-grade meningiomas and the cell types and signaling mechanisms that drive meningioma tumorigenesis and resistance to radiotherapy are incompletely understood. Here, we report that NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy and find that perivascular NOTCH3+ stem cells are conserved across meningiomas from humans, dogs, and mice. Integrating single-cell transcriptomics with lineage tracing and imaging approaches in genetically engineered mouse models and xenografts, we show NOTCH3 drives tumor-initiating capacity, cell proliferation, angiogenesis, and resistance to radiotherapy to increase meningioma growth and reduce survival. To translate these findings to patients, we show that an antibody stabilizing the extracellular negative regulatory region of NOTCH3 blocks meningioma tumorigenesis and sensitizes meningiomas to radiotherapy, reducing tumor growth and improving survival. Significance: There are no effective systemic therapies to treat meningiomas, and meningioma stem cells are poorly understood. Here, we report perivascular NOTCH3+ stem cells to drive meningioma tumorigenesis and resistance to radiotherapy. Our results identify a conserved mechanism and a therapeutic vulnerability to treat meningiomas that are resistant to standard interventions.

Citing Articles

Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells.

Tang H, Xu F, Sun D, Hua L, Xiong J, Xu M CNS Neurosci Ther. 2025; 31(2):e70287.

PMID: 39996452 PMC: 11851153. DOI: 10.1111/cns.70287.

Meningeal solitary fibrous tumor cell states phenocopy cerebral vascular development and homeostasis.

Mirchia K, Choudhury A, Joseph T, Birrueta J, Phillips J, Bhaduri A Neuro Oncol. 2024; 27(1):155-166.

PMID: 39207122 PMC: 11726342. DOI: 10.1093/neuonc/noae172.

Glioblastoma Neurovascular Progenitor Orchestrates Tumor Cell Type Diversity.

Fazzari E, Azizad D, Yu K, Ge W, Li M, Nano P bioRxiv. 2024; .

PMID: 39091877 PMC: 11291138. DOI: 10.1101/2024.07.24.604840.

Glioblastoma Phagocytic Cell Death: Balancing the Opportunities for Therapeutic Manipulation.

Du R, Tripathi S, Najem H, Brat D, Lukas R, Zhang P Cells. 2024; 13(10).

PMID: 38786045 PMC: 11119757. DOI: 10.3390/cells13100823.

Semi-automated approaches for interrogating spatial heterogeneity of tissue samples.

Navikas V, Kowal J, Rodriguez D, Rivest F, Brajkovic S, Cassano M Sci Rep. 2024; 14(1):5025.

PMID: 38424144 PMC: 10904364. DOI: 10.1038/s41598-024-55387-w.

References

Tournier-Lasserve E, Joutel A, Melki J, Weissenbach J, Lathrop G, Chabriat H . Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy maps to chromosome 19q12. Nat Genet. 1993; 3(3):256-9. DOI: 10.1038/ng0393-256. View

Goldbrunner R, Stavrinou P, Jenkinson M, Sahm F, Mawrin C, Weber D . EANO guideline on the diagnosis and management of meningiomas. Neuro Oncol. 2021; 23(11):1821-1834. PMC: 8563316. DOI: 10.1093/neuonc/noab150. View

Raleigh D, Preusser M . A 34-gene expression biomarker predicts meningioma outcomes and radiotherapy responses. Neuro Oncol. 2023; 26(2):207-208. PMC: 10836762. DOI: 10.1093/neuonc/noad212. View

Snyder J, Shofer F, Van Winkle T, Massicotte C . Canine intracranial primary neoplasia: 173 cases (1986-2003). J Vet Intern Med. 2006; 20(3):669-75. DOI: 10.1892/0891-6640(2006)20[669:cipnc]2.0.co;2. View

Wei K, Korsunsky I, Marshall J, Gao A, Watts G, Major T . Notch signalling drives synovial fibroblast identity and arthritis pathology. Nature. 2020; 582(7811):259-264. PMC: 7841716. DOI: 10.1038/s41586-020-2222-z. View

Hanahan D . Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022; 12(1):31-46. DOI: 10.1158/2159-8290.CD-21-1059. View

Nakamura M, Roser F, Bundschuh O, Vorkapic P, Samii M . Intraventricular meningiomas: a review of 16 cases with reference to the literature. Surg Neurol. 2003; 59(6):491-503; discussion 503-4. DOI: 10.1016/s0090-3019(03)00082-x. View

Zheng Y, de la Cruz C, Sayles L, Alleyne-Chin C, Vaka D, Knaak T . A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires Notch3 for self-renewal. Cancer Cell. 2013; 24(1):59-74. PMC: 3923526. DOI: 10.1016/j.ccr.2013.05.021. View

Incarbone M, Ceresoli G, Di Tommaso L, Cappuzzo F, Inzirillo F, Infante M . Primary pulmonary meningioma: report of a case and review of the literature. Lung Cancer. 2008; 62(3):401-7. DOI: 10.1016/j.lungcan.2008.03.031. View

10.

Ianevski A, Giri A, Aittokallio T . Fully-automated and ultra-fast cell-type identification using specific marker combinations from single-cell transcriptomic data. Nat Commun. 2022; 13(1):1246. PMC: 8913782. DOI: 10.1038/s41467-022-28803-w. View

11.

Siegenthaler J, Choe Y, Patterson K, Hsieh I, Li D, Jaminet S . Foxc1 is required by pericytes during fetal brain angiogenesis. Biol Open. 2013; 2(7):647-59. PMC: 3711032. DOI: 10.1242/bio.20135009. View

12.

Zarbalis K, Siegenthaler J, Choe Y, May S, Peterson A, Pleasure S . Cortical dysplasia and skull defects in mice with a Foxc1 allele reveal the role of meningeal differentiation in regulating cortical development. Proc Natl Acad Sci U S A. 2007; 104(35):14002-7. PMC: 1955817. DOI: 10.1073/pnas.0702618104. View

13.

Tang K, Dai Y, Tong M, Chan Y, Kwan P, Fu L . A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer. Cancer Res. 2013; 73(7):2322-32. DOI: 10.1158/0008-5472.CAN-12-2991. View

14.

Lin D, Lin J, Deng X, Li W, Li D, Yin B . Trends in intracranial meningioma incidence in the United States, 2004-2015. Cancer Med. 2019; 8(14):6458-6467. PMC: 6797634. DOI: 10.1002/cam4.2516. View

15.

Brastianos P, Galanis E, Butowski N, Chan J, Dunn I, Goldbrunner R . Advances in multidisciplinary therapy for meningiomas. Neuro Oncol. 2019; 21(Suppl 1):i18-i31. PMC: 6347080. DOI: 10.1093/neuonc/noy136. View

16.

Maas S, Stichel D, Hielscher T, Sievers P, Berghoff A, Schrimpf D . Integrated Molecular-Morphologic Meningioma Classification: A Multicenter Retrospective Analysis, Retrospectively and Prospectively Validated. J Clin Oncol. 2021; 39(34):3839-3852. PMC: 8713596. DOI: 10.1200/JCO.21.00784. View

17.

Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P . Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature. 1996; 383(6602):707-10. DOI: 10.1038/383707a0. View

18.

Tsai J, Goldman C, Gillespie G . Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg. 1995; 82(5):864-73. DOI: 10.3171/jns.1995.82.5.0864. View

19.

Hafemeister C, Satija R . Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 2019; 20(1):296. PMC: 6927181. DOI: 10.1186/s13059-019-1874-1. View

20.

Kalamarides M, Stemmer-Rachamimov A, Niwa-Kawakita M, Chareyre F, Taranchon E, Han Z . Identification of a progenitor cell of origin capable of generating diverse meningioma histological subtypes. Oncogene. 2011; 30(20):2333-44. DOI: 10.1038/onc.2010.609. View